Read about Endologix
in the news

Embrace the evidence.

The Latest:

One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)

See Release

2021 News


Endologix Announces Completion of Enrollment in the TORUS 2 Study for PAD in SFA

Endologix Names Dr. Matthew Thompson President and CEO

Endologix Initiates Randomized Study of ALTO® Abdominal Stent Graft System

Endologix LLC Receives FDA Breakthrough Device Designation for ChEVASTM System

Endologix LLC Announces Launch of ALTO® Abdominal Stent Graft System in Canada and Argentina Company Expands Global Reach with Latest Endovascular Aneurysm Repair (EVAR) Technology